Brief: Matinas Biopharma QTRLY Loss Per Share $ 0.03
Nov 12 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA REPORTS THIRD QUARTER 2018 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* MATINAS BIOPHARMA HOLDINGS INC - QTRLY LOSS PER SHARE $
0.03
* MATINAS BIOPHARMA HOLDINGS INC - BELIEVE TOTAL CASH AND
CASH
EQUIVALENTS AS OF DATE SUFFICIENT TO FUND PLANNED OPERATIONS
THROUGH NOV 2019
Source text for Eikon: ID:nGNX324Nt6
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing
Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Brief: Matinas Biopharma Holdings Inc - CFO Keith Kucinski Resigns Effective January 17, 2026 - SEC Filing
Brief: Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma
Brief: Matinas BioPharma Appoints Seasoned Biotech Leaders To Board Of Directors